Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Brain Imaging01:14

Brain Imaging

670
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
670

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Psychedelics disrupt hierarchical cortical propagations in the default mode network of humans and mice.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Integrative learning of individualized treatment rules from multiple studies with partially overlapping treatments.

Biometrics·2026
Same author

Reply: Matters Arising: The importance of understanding AI's impact on physician behavior.

Npj mental health research·2025
Same author

Brain activity explains message effectiveness: A mega-analysis of 16 neuroimaging studies.

PNAS nexus·2025
Same author

A novel experimental vignette methodology: SMART vignettes.

Methodological innovations·2025
Same author

Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot study.

Journal of affective disorders·2025

相关实验视频

Updated: Jan 18, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.2K

在精神病学中开发临床可解释的神经成像生物型

Jeesung Ahn1, Lara C Foland-Ross1, Teddy J Akiki2

  • 1Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.

Biological psychiatry
|September 10, 2025
PubMed
概括
此摘要是机器生成的。

功能磁共振成像 (fMRI) 可以预测主要抑郁症 (MDD) 治疗结果. 将治疗方法与个体大脑电路配置相匹配,可能会使缓解率增加一倍,从而改善对这种残疾人的护理.

关键词:
抑郁症生物型类型功能神经成像功能神经成像神经电路的神经电路.精准医学在精神病学中的应用.治疗方法 治疗方法

更多相关视频

Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies
04:25

Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies

Published on: December 15, 2023

3.8K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.5K

相关实验视频

Last Updated: Jan 18, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.2K
Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies
04:25

Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies

Published on: December 15, 2023

3.8K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.5K

科学领域:

  • 神经科学是一个神经科学.
  • 精神病学是一个精神病学.
  • 医疗成像医学成像

背景情况:

  • 重度抑郁症 (MDD) 是导致残疾的主要原因,其特点是患者呈现异质,缺乏指导治疗的生物标志物.
  • 目前对MDD的诊断和治疗方法依赖于基于症状的评估和试错的处方,导致初始缓解率低 (33%) 和复发风险高 (50-90%).
  • 由于MDD的异质性,需要开发客观的方法来个性化治疗选择并改善患者的治疗结果.

研究的目的:

  • 审查和综合表明功能磁共振成像 (fMRI) 在预测MDD治疗反应中的实用性研究.
  • 为了说明一种基于fMRI的特定方法来量化大脑电路功能障碍及其在个性化治疗匹配中的应用.
  • 讨论精确成像方法在解决MDD异质性和改善临床实践方面的潜力.

主要方法:

  • 对关于fMRI应用在预测MDD治疗结果方面的现有文献进行批判性审查.
  • 使用fMRI的六个大规模生物型电路中的功能障碍量化的理论上知情的方法的说明.
  • 分析个性化电路分数作为治疗反应的预测指标和差异性治疗结果的调节者.

主要成果:

  • 基于fMRI的个性化电路得分可以预测MDD患者的治疗反应或失败.
  • 与个体特定的大脑电路配置 (生物型) 相匹配的治疗有可能使缓解率与标准,无匹配的治疗相比增加一倍.
  • 这种方法为分析MDD的异质性提供了生物学基础,超越了基于症状的分类.

结论:

  • 基于fMRI的生物标志物对个性化MDD治疗和改善缓解率具有重大前景.
  • 将这些精确成像工具转化为常规的临床实践需要解决当前的挑战和局限性.
  • 未来的研究应该专注于完善fMRI方法,并验证它们对MDD管理的临床实用性.